See How Easy It Can Be to Get Expert Results for Biologics Characterization

Feb 7, 2017 | Biopharma, Blogs | 0 comments

Learning a new mass spec system can be a daunting task. Aside from the opportunity costs of training new users, you might face the hassle of downtime, and the wait to get expert help when needed. The X500B QTOF system puts a new spin on biologics characterization workflows because it is so easy to learn and operate that you can be up and running much faster than you expect. Powerful new software tools dramatically streamline method development and data processing, to enable everyone in your lab to get expert results. It’s fast because it’s easy, even for new users.

Intact Mass Analysis: Rapid Answers with Confidence
New BioPharmaView™ Software 2.0 combines perfectly with the X500B QTOF system, to put powerful data processing tools for visualization and comparisons at your fingertips. You only need to provide protein sequence and potential modification information, since BioPharmaView Software automates intact protein deconvolution in seconds. In BioPharmaView software you’re able to:

  • Reduce variability and improve comparability
  • Rapidly interpret your data with powerful graphical post-translational modification analysis
  • Display your raw data alongside deconvoluted output for more confident answers

Discover how automated, and lightning fast drug-antibody ratio (DAR) calculations in BioPharmaView Software allow for easy sample comparison, so you can spend less time on manual calculations and more time on visualizing drug load. Add to that easy one-click batch processing and automated ratio calculations for post-translational modification analysis. You’ll see how straightforward it is to rapidly identify and visualize differences between samples to make direct comparisons in either the raw MS spectra or deconvoluted protein results.

Peptide Mapping: Unbiased Comprehensive Analysis
SCIEX OS operating software built into the X500B QTOF system makes comprehensive peptide mapping easier with new workflows: simplified acquisition and streamlined peptide mapping analysis ensure everyone can get great results with just a few clicks.

The X500B system supports traditional Information or Data-Dependent Acquisition (IDA or DDA) methods, as well as proprietary SWATH® Information Independent Acquisition (IDA) for comprehensive identification of even low abundance peptides and post-translational modifications. SWATH Acquisition employs an unbiased acquisition strategy, where every precursor is targeted for MS/MS analysis, so you don’t need to worry about missing important attributes.

Using the X500B system and BioPharmaView Software, you’ll be able to analyze peptide mapping data in just four steps using, so you can make better decisions faster about your biologics products:

  1. Define your biotherapeutic sequences and disulfide bonds
  2. Add custom modifications for samples like ADCs
  3. Save your assay information for batch processing
  4. Generate comprehensive reports in multiple output formats

Fill out the form in the top right of this blog to download the Intact Mass Analysis and Peptide Mapping Solution Guides. These guides show how improved data acquisition and analysis workflows with SCIEX OS and BioPharmaView Software for the X500B QTOF System can transform your biotherapeutic characterization.

 

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network